Skip to main content

4 Result(s)

within E. Torlakovic Remove this filter

and

  1. Article

    Open Access

    Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL

    In personalized medicine, predictive biomarker testing is the basis for an appropriate choice of therapy for patients with cancer. An important tool for laboratories to ensure accurate results is participation...

    K. Dufraing, F. Fenizia, E. Torlakovic, N. Wolstenholme, Z. C. Deans… in Virchows Archiv (2021)

    Download PDF (525 KB) View Article

  2. No Access

    Article

    Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts

    Historically, our understanding of mechanisms underlying human leukemogenesis are inferred from genetically engineered mouse models. Relatively, few models that use primary human cells recapitulate the full le...

    A P A Theocharides, S M Dobson, E Laurenti, F Notta, V Voisin, P-Y Cheng… in Leukemia (2015)

  3. No Access

    Article

    High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin’s lymphoma

    From August 1987 to March 1995, 25 patients with high-grade B cell non-Hodgkin’s lymphoma (NHL) were treated with high-dose therapy (HDT) followed by bone marrow purged with immunomagnetic beads. At the time o...

    AK Blystad, G Kvalheim, E Torlakovic, H Holte, E Jacobsen… in Bone Marrow Transplantation (1999)

  4. No Access

    Article

    Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia

    A patient previously diagnosed with chronic neutrophilic leukemia (CNL) was studied using fluorescent in situ hybridization (FISH) to determine clonality of neutrophils. By cytogenetic studies the patient’s blood...

    MK Froberg, RD Brunning, P Dorion, CE Litz, E Torlakovic in Leukemia (1998)